United KingdomHaberleri

Pfizer Submits Data to FDA for COVID-19 Vaccine in Children 5 to 11

Pfizer-BioNTech has submitted initial trial data to the Food and Drug Administration to clear its COVID-19 vaccine for use in children ages 5 to 11, officials announced Tuesday. The FDA is expected to take at least several weeks to analyze data collected in a trial that included more than 2,000 children before it would grant emergency use authorization. A formal submission to request emergency use authorization of the companies’ vaccine is expected to follow in the coming weeks, officials said in a release. The two-dose vaccine, which is already authorized in teens aged 12 to 15 and fully approved for ages 16 and up, has shown to be safe, while prompting a “well tolerated” and “robust” antibody response among the younger, targeted group. Read the full story on NBCNews.com.

uk news

114
Bize Ulaşın

Merkez mahallesi mutlu han sokak no:17/2 Bartın/Sakarya

info@uknews.com.tr

uknews.com.tr adresinde yer alan haberlerin iktibas edilirken kaynak gösterilmesini bekleriz.
Sitemizde yer alan haberin telif hakları nbcchicago firmasına aittir, kaynak gösterilmeden ve link verilmeden iktibas edilemezler.
Haber Sitesi Bu içeriğin kullanımıyla ilgili yasal yükümlülükler kullanıcıya aittir.